Dynavax Technologies Balance Sheet Health
Financial Health criteria checks 6/6
Dynavax Technologies has a total shareholder equity of $622.1M and total debt of $222.7M, which brings its debt-to-equity ratio to 35.8%. Its total assets and total liabilities are $997.1M and $375.0M respectively.
Key information
35.8%
Debt to equity ratio
US$222.70m
Debt
| Interest coverage ratio | n/a |
| Cash | US$742.30m |
| Equity | US$622.07m |
| Total liabilities | US$375.02m |
| Total assets | US$997.10m |
Recent financial health updates
Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06
These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12Dynavax Technologies (NASDAQ:DVAX) Could Easily Take On More Debt
May 10Recent updates
Dynavax: Holding Firm Despite Its Missing Cash Cow
Mar 23Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06Dynavax Technologies Corporation's (NASDAQ:DVAX) Business And Shares Still Trailing The Industry
Jan 31These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02Improved Earnings Required Before Dynavax Technologies Corporation (NASDAQ:DVAX) Shares Find Their Feet
Jun 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Clover, Dynavax COVID-19 vaccine gets EU GMP certificate
Sep 20Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12The Alphavaxers: Dynavax And Novavax, 2 Quarters On
Aug 22Dynavax up 8% after raising full-year guidance for key adjuvant product, Q2 beats
Aug 04Are Investors Undervaluing Dynavax Technologies Corporation (NASDAQ:DVAX) By 41%?
Jun 03Dynavax: Evolving Endemic Situation Adds To Its Risk
May 23Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest
May 12Dynavax Technologies (NASDAQ:DVAX) Could Easily Take On More Debt
May 10Dynavax Technologies: Full Speed Ahead
Mar 01Here's Why Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt Responsibly
Jan 28Dynavax: A Coronavirus Growth Story
Jan 17Is Dynavax Technologies Corporation (NASDAQ:DVAX) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 18The Momentum Investor: Spotlight On Dynavax Technologies
Oct 25Dynavax And TLR Biology: Long-Delayed But Outstanding Success
Oct 16These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Reasonably Well
Oct 02Upgrade: Analysts Just Made A Meaningful Increase To Their Dynavax Technologies Corporation (NASDAQ:DVAX) Forecasts
Aug 10Dynavax: Earnings This Year Ought To Surprise To The Upside
Aug 01Is Dynavax Technologies (NASDAQ:DVAX) Weighed On By Its Debt Load?
May 30Dynavax shares down 6% on launch of $200M debt offering
May 10Financial Position Analysis
Short Term Liabilities: DVAX's short term assets ($859.1M) exceed its short term liabilities ($62.2M).
Long Term Liabilities: DVAX's short term assets ($859.1M) exceed its long term liabilities ($312.8M).
Debt to Equity History and Analysis
Debt Level: DVAX has more cash than its total debt.
Reducing Debt: DVAX's debt to equity ratio has reduced from 159.9% to 35.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable DVAX has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: DVAX is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 46.2% per year.